Ophthalmic Drugs Market Size, Growth, Key Players, Analysis and Forecast 2026-2034

The global ophthalmic drugs market features established multinational pharmaceutical corporations alongside emerging biotech innovators. Key companies profiled in the IMARC Group report include:

• AbbVie Inc.
• Aerie Pharmaceuticals Inc.
• Akorn Inc.
• Alcon
• Bausch Health Companies Inc.
• Bayer AG
• F. Hoffmann-La Roche AG
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
• Sun Pharmaceutical Industries Ltd.

Key players are actively engaged in R&D investments, clinical trial expansions, combination therapy development, novel delivery system patents, strategic acquisitions, and pipeline licensing to maintain competitive positioning and drive ophthalmic drugs market growth. Leading corporations such as Novartis, Roche, and Pfizer are pioneering new drug delivery technologies to optimize therapeutic effectiveness and patient compliance.

Latest Industry Developments

February 2023: Bayer AG proposed aflibercept 8mg for regulatory approval in the EU for two major retinal illnesses, representing a significant pipeline advancement in the treatment of AMD and diabetic macular edema.

March 2022: Thea Pharma announced the acquisition of seven branded ophthalmic products from Akorn Operating Company LLC, reinforcing its position as a major provider of specialist eye care products and expanding its ophthalmic drugs market share.

January 2023: Bausch Health Companies Inc. announced the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins, a therapeutic solution for individuals diagnosed with moderate-to-advanced AMD, broadening the company’s product portfolio in the retinal disorder segment.

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Technology, Construction, Healthcare, Energy, Food & Beverages, and more.

Contact Us:

IMARC Group

United States: +1-201-971-6302